State of Wisconsin Investment Board’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

State of Wisconsin Investment Board’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-134,200	Closed	-$510K	–	1833
2020 Q1	$510K	Buy	134,200 +6,600	+5%	+$28.4K	﹤0.01%	1347
2019 Q4	$649K	Hold	127,600	–	–	﹤0.01%	1356
2019 Q3	$645K	Buy	127,600 +12,300	+11%	+$61.3K	﹤0.01%	1253
2019 Q2	$711K	Buy	115,300 +2,500	+2%	+$12.1K	﹤0.01%	1236
2019 Q1	$523K	Buy	112,800 +25,900	+30%	+$117K	﹤0.01%	1337
2018 Q4	$365K	Buy	86,900 +11,400	+15%	+$58K	﹤0.01%	1387
2018 Q3	$473K	Hold	75,500	–	–	﹤0.01%	1411
2018 Q2	$607K	Buy	75,500 +22,500	+42%	+$172K	﹤0.01%	1315
2018 Q1	$395K	Hold	53,000	–	–	﹤0.01%	1340
2017 Q4	$315K	Hold	53,000	–	–	﹤0.01%	1357
2017 Q3	$390K	Hold	53,000	–	–	﹤0.01%	1340
2017 Q2	$360K	Buy	+53,000	New	+$391K	﹤0.01%	1348

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

State of Wisconsin Investment Board's PGNX Position: Q2 2020 in Review

State of Wisconsin Investment Board sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 134,200 shares — an estimated $510K sold.

State of Wisconsin Investment Board first reported a position in PGNX in Q2 2017 and held it in 12 quarters. The position peaked at $711K in Q2 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

State of Wisconsin Investment Board reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
State of Wisconsin Investment Board sold 134,200 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $510K.
State of Wisconsin Investment Board first reported a position in Progenics Pharmaceuticals Inc in Q2 2017 and held it in 12 quarters.
State of Wisconsin Investment Board's Progenics Pharmaceuticals Inc position peaked at $711K in Q2 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2020, filed 12 Aug 2020.